<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-14T12:57:16Z</responseDate><request verb="GetRecord" identifier="oai:gredos.usal.es:10366/159266" metadataPrefix="mods">https://gredos.usal.es/oai/request</request><GetRecord><record><header><identifier>oai:gredos.usal.es:10366/159266</identifier><datestamp>2025-04-30T19:33:31Z</datestamp><setSpec>com_10366_3992</setSpec><setSpec>com_10366_3947</setSpec><setSpec>com_10366_3946</setSpec><setSpec>com_10366_3823</setSpec><setSpec>col_10366_3993</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>García Domingo, Mónica</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Morán Benito, Asunción</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Calama, Elena</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Martín Calvo, María Luisa</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Barthelmebs, Mariette</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>San Román del Barrio , Luis</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2024-07-31T08:04:29Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2024-07-31T08:04:29Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2005-07</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">García, M., Morán, A., Calama, E., Martín, M. L., Barthelmebs, M., &amp; Román, L. S. (2005). Diabetes‐induced changes in the 5‐hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat. British journal of pharmacology, 145(5), 593-601.</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10366/159266</mods:identifier>
<mods:identifier type="doi">doi.org/10.1038/sj.bjp.0706216</mods:identifier>
<mods:identifier type="essn">1476-5381</mods:identifier>
<mods:abstract>[EN] We investigated the effect of alloxan-induced diabetes on the inhibitory mechanisms of 5-hydroxytryptamine (5-HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in pithed rats, and analysed the type and/or subtype of 5-HT receptors involved. 2. Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan, then 4 weeks later, they were anaesthetized, pretreated with atropine and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency-dependent increases in blood pressure. 3. Intravenous infusions of 5-HT (1-80 microg kg(-1) min(-1)) reduced the pressor effects obtained by electrical stimulation. The 5-HT(1) receptor agonist 5-carboxamidotryptamine, 5-CT (5 microg kg(-1) min(-1)), caused an inhibition of the pressor response, whereas the selective 5-HT(2) receptor agonist, alpha-methyl-5-HT (5 microg kg(-1) min(-1)) and the selective 5-HT(3) receptor agonist, 1-phenylbiguanide (40 microg kg(-1) min(-1)), did not modify the sympathetic pressor responses. 5-HT had no effect on exogenous noradrenaline (NA)-induced pressor responses. 4. The inhibition of electrically induced pressor responses by 5-HT (10 microg kg(-1) min(-1)) was unable to be elicited after i.v. treatment with methiothepin (100 microg kg(-1)) because of the marked inhibition produced by methiothepin alone. The 5-HT-induced inhibition was blocked after i.v. administration of WAY-100,635 (100 microg kg(-1)) and not affected by ritanserin (1 mg kg(-1)), MDL 72222 (2 mg kg(-1)). 5. The selective 5-HT(1A) receptor agonist, 8-hydroxydipropylaminotretalin hydrobromide (8-OH-DPAT) (5-20 microg kg(-1) min(-1)) but neither the rodent 5-HT(1B) receptor agonist, CGS-12066B (5 microg kg(-1) min(-1)), nor the selective nonrodent 5-HT(1B) and 5-HT(1D) receptor agonist, L-694,247 (5 and 40 microg kg(-1) min(-1)), inhibited the electrically induced pressor response. The selective 5-HT(1A) receptor antagonist, WAY-100,635 (100 microg kg(-1)), blocked the inhibition induced by 8-OH-DPAT (10 microg kg(-1) min(-1)). 8-OH-DPAT had no effect on exogenous NA-induced pressor responses. 6. Experimental diabetes produces changes in the inhibitory effect induced by 5-HT on electrically induced sympathetic pressor responses, such that the inhibitory action induced by 5-HT in diabetic pithed rats is mediated by prejunctional 5-HT(1A) receptors.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:subject>
<mods:topic>5-hydroxytryptamine</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>experimental diabetes</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>5-CT</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>5-HT1A receptors</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>prejunctional inhibition</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>